Watch Ticker

Insmed, Inc.

Go to Insmed, Inc. Website

$111.24

2.55 (2.35%)

Live

Previous Close

$108.69

Day Range

$108 - $111.28

Previous Day Range

$105.75 - $108.89

Market Cap

$20.6 billion USD

Day Vol.

2.2 million

Previous Day Vol.

2.3 million

Currency

USD

Primary Exchange

Nasdaq

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Marketbeat.Com - Russell Rebalance: 3 Stocks Ready to Move Higher

The article discusses three stocks that could see a price increase due to the upcoming Russell index rebalancing: Sprouts Farmers Market (SFM), Insmed (INSM), and FTAI Aviation (FTAI).

Related tickers: INSM, FTAI, FTAIM, FTAIN.

Read Full Article

Vandana Singh - Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast

Insmed's treprostinil palmitil inhalation powder (TPIP) for pulmonary arterial hypertension met its primary and secondary endpoints, exceeding analysts' expectations. Analysts have raised their price targets for Insmed, citing the strong data and upcoming catalysts.

Related tickers: INSM.

Read Full Article

Trending Tickers

Please sign in to view